Michael V Rocco
Overview
Explore the profile of Michael V Rocco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
6909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pajewski N, Beddhu S, Bress A, Chang T, Chertow G, Cheung A, et al.
J Am Soc Nephrol
. 2024 Jul;
35(12):1737-1745.
PMID: 39078712
No abstract available.
2.
Sinha R, Rocco M, Daeihagh P, Staples A
Nat Rev Nephrol
. 2024 Mar;
20(5):269-270.
PMID: 38438536
No abstract available.
3.
Drawz P, Lenoir K, Rai N, Rastogi A, Chu C, Rahbari-Oskoui F, et al.
Clin J Am Soc Nephrol
. 2023 Oct;
19(2):213-223.
PMID: 37883184
Background: Intensive BP lowering in the Systolic Blood Pressure Intervention Trial (SPRINT) produced acute decreases in kidney function and higher risk for AKI. We evaluated the effect of intensive BP...
4.
Rocco M, Rigaud M, Ertel C, Russell G, Zemdegs J, Vecchio M
Kidney Med
. 2023 Sep;
5(9):100703.
PMID: 37663954
Rationale & Objective: Increased interdialytic weight gain (IDWG) has been associated with increased morbidity and mortality. We evaluated the usefulness and safety of a mobile application (app) that allows patients...
5.
Chu C, Lenoir K, Rai N, Soman S, Dwyer J, Rocco M, et al.
Contemp Clin Trials
. 2023 Apr;
128:107172.
PMID: 37004812
Background: Randomized trials are the gold standard for generating clinical practice evidence, but follow-up and outcome ascertainment are resource-intensive. Electronic health record (EHR) data from routine care can be a...
6.
Jaeger B, Bress A, Bundy J, Cheung A, Cushman W, Drawz P, et al.
JAMA Cardiol
. 2022 Oct;
7(11):1138-1146.
PMID: 36223105
Importance: The Systolic Blood Pressure Intervention Trial (SPRINT) showed that intensive blood pressure control reduced cardiovascular morbidity and mortality. However, the legacy effect of intensive treatment is unknown. Objective: To...
7.
Inker L, Ferre S, Baliker M, Barr A, Bonebrake L, Chang A, et al.
Am J Kidney Dis
. 2022 Oct;
81(2):210-221.e1.
PMID: 36191726
Rationale & Objective: The National Kidney Foundation (NKF) launched the first national US kidney disease patient registry, the NKF Patient Network, that is open to patients throughout the continuum of...
8.
Kramer H, Jaar B, Choi M, Palevsky P, Vassalotti J, Rocco M
Am J Kidney Dis
. 2022 Sep;
80(6):691-696.
PMID: 36058427
No abstract available.
9.
Drawz P, Rai N, Lenoir K, Suarez M, Powell J, Raj D, et al.
Kidney360
. 2022 Aug;
3(7):1253-1262.
PMID: 35919535
Background: Adjudication of inpatient AKI in the Systolic Blood Pressure Intervention Trial (SPRINT) was based on billing codes and admission and discharge notes. The purpose of this study was to...
10.
Bae E, Rocco M, Lee J, Park J, Kim Y, Yoo K, et al.
J Hypertens
. 2021 Dec;
40(1):108-116.
PMID: 34857704
Introduction: Hypertension is common and has a significant effect on cardiovascular morbidity and death. However, despite the development of several guidelines to manage SBP, there is little research or guidance...